KR20210075705A - Composition comprising extracts of Orostachys japonicus as an active ingredient for preventing, alleviating or treating diabetes - Google Patents

Composition comprising extracts of Orostachys japonicus as an active ingredient for preventing, alleviating or treating diabetes Download PDF

Info

Publication number
KR20210075705A
KR20210075705A KR1020190167097A KR20190167097A KR20210075705A KR 20210075705 A KR20210075705 A KR 20210075705A KR 1020190167097 A KR1020190167097 A KR 1020190167097A KR 20190167097 A KR20190167097 A KR 20190167097A KR 20210075705 A KR20210075705 A KR 20210075705A
Authority
KR
South Korea
Prior art keywords
wasong
confirmed
extract
alcohol extract
hot water
Prior art date
Application number
KR1020190167097A
Other languages
Korean (ko)
Inventor
서정훈
신동규
차정단
고은실
조상민
정종훈
강제란
이솔
김범석
김종원
정현의
Original Assignee
제너럴바이오(주)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 제너럴바이오(주) filed Critical 제너럴바이오(주)
Priority to KR1020190167097A priority Critical patent/KR20210075705A/en
Publication of KR20210075705A publication Critical patent/KR20210075705A/en

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105Plant extracts, their artificial duplicates or their derivatives
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L5/00Preparation or treatment of foods or foodstuffs, in general; Food or foodstuffs obtained thereby; Materials therefor
    • A23L5/20Removal of unwanted matter, e.g. deodorisation or detoxification
    • A23L5/23Removal of unwanted matter, e.g. deodorisation or detoxification by extraction with solvents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/41Crassulaceae (Stonecrop family)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00Function of food ingredients
    • A23V2200/30Foods, ingredients or supplements having a functional effect on health
    • A23V2200/328Foods, ingredients or supplements having a functional effect on health having effect on glycaemic control and diabetes
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2300/00Processes
    • A23V2300/14Extraction

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Botany (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nutrition Science (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

The present invention relates to a food composition for preventing or alleviating diabetes containing an Orostachys japonica extract as an active component. Accordingly, the present invention can minimize side effects in the human body using plants, and thus can prevent, alleviate or treat diabetes by activating pancreatic beta cells while lowering blood sugar levels to a normal range.

Description

와송 추출물을 유효성분으로 함유하는 당뇨 예방, 개선 또는 치료용 조성물 {Composition comprising extracts of Orostachys japonicus as an active ingredient for preventing, alleviating or treating diabetes}A composition comprising extracts of Orostachys japonicus as an active ingredient for preventing, alleviating or treating diabetes comprising a Wasong extract as an active ingredient.

본 발명은 와송 추출물을 유효성분으로 함유하여 당뇨를 예방, 개선하거나 치료하는 용도의 조성물에 관한 것이다.The present invention relates to a composition for preventing, improving or treating diabetes by containing a Wasong extract as an active ingredient.

당뇨병은 탄수화물 대사에 작용하는 인슐린(insulin)의 작용이 정상적으로 이루어지지 않아 일어나는 내분비 장애의 가장 대표적인 질병으로, 주로 소아에서 발생하며 췌장 (pancreas)의 인슐린 분비가 감소에 의한 제1형 당뇨병 및 성인에서 주로 발생하며 인체 각 조직이 인슐린에 대해 무반응성의 인슐린 저항성 증상을 나타내는 제2형 당뇨병으로 분류된다.Diabetes mellitus is the most representative disease of endocrine disorders caused by the failure of insulin, which acts on carbohydrate metabolism, to function normally. It occurs mainly and is classified as type 2 diabetes in which each tissue in the body exhibits symptoms of insulin resistance and non-responsiveness to insulin.

당뇨병의 주된 치료제로서는 설포닐우레아 (sulfonylureas)계 약물, 비구아니드 (biguanides)계 등의 경구로 섭취하는 혈당강하제와 DNA 재조합법에 의하여 얻은 인슐린 등이 사용되고 있다. 하지만 이런 약물들은 저혈당증 유발, 신장독성, 유산증, 설사와 배탈, 면역거부반응 등 많은 부작용을 가지고있어 부작용이 적은 천연물을 이용하려는 연구가 활발해지고 있다.As the main therapeutic agents for diabetes, sulfonylureas-based drugs, biguanides-based orally ingested hypoglycemic agents, and insulin obtained by DNA recombination are used. However, these drugs have many side effects, such as hypoglycemia induction, renal toxicity, lactic acidosis, diarrhea and upset stomach, and immune rejection.

한편, 와송(瓦松)은 바위솔(Orostachys japonicus A. Berger)이라 하며 일명 암송(岩松), 옥송(屋松), 작엽하초(昨葉何草) 등으로 불리는 돌나물과(Crassulaceae)의 다년생 초본 식물로서 한방에서 해열, 소종, 지혈, 이습 등에 사용되며[金在佶, 1984, 原色天然藥物大事典(上卷), 南山堂, 서울, p.447] 민간요법으로 암치료에도 많이 이용되고 있다[배성식,1990, 한방과 건강, 1, 26].On the other hand, Wasong (瓦松) is called Orostachys japonicus A. Berger, and is a perennial herbaceous plant of the Crassulaceae family, also called cypress (岩松), jade pine (屋松), and sedumaceae (昨葉何草). It is used in oriental medicine for antipyretic, epilepsy, hemostasis, and eczema [金在佶, 1984, 原色天然藥物大事典(上卷), Namsan堂, Seoul, p.447] and is widely used in cancer treatment as folk remedies [ Bae Seong-sik, 1990, Oriental Medicine and Health, 1, 26].

이 식물은 바위 곁에 붙어서 자라는 육질의 다년생 초본이지만 꽃이 피고 열매를 맺으면 고사하는 특징이 있다. 근생엽은 로제트형으로 퍼지며 끝이 굳어져서 가시처럼 되고 원줄기에 잎이 달리며 엽병이 없고 여름철에 나오는 근생엽과 더불어 끝이 굳어지지 않고 다만 뾰족해질 뿐이며 피침형으로서 녹색이지만 자주색 또는 분을 칠한 듯한 백색인것도 있다. 꽃은 9월에 피고 백색이며 총상화서는 길이 6∼15cm로서 화병이 없는 꽃이 밀착하고 포는 피침형이며 끝이 뾰족하다. 꽃받침은 5개로서 피침형이고 녹색이며 꽃잎도 5개로서 피침형 예두이고 길이 6mm 정도이다. 수술은10개이며 꽃잎보다 길고 자방은 5개이며 화분은 적색이지만 점차 흑색으로 된다[이창복, 1979, 大韓植物圖鑑, 鄕文社 서울, p.402]. 와송은 여름부터 가을에 걸쳐 채취하며 뿌리를 제거한 전초(全草)를 햇볕에 말려 약용으로 한다[金在佶, 1984, 原色天然藥物大事典(上卷), 南山堂, 서울, p.447].Although this plant is a fleshy perennial herb that grows by attaching to rocks, it has a characteristic that it dies when flowers bloom and bear fruit. The rosette-shaped leaves spread in a rosette-like shape and become thorn-like with leaves hanging on the main stem, without petioles. Together with the rosette leaves in summer, the end does not harden but only becomes sharp. It is lanceolate, green, but purple or white. have. The flowers bloom in September and are white, and the raceme is 6-15cm long, and the flowers without a vase are closely attached, and the bracts are lanceolate and have a sharp tip. The sepals are 5, lanceolate, green, and 5 petals, lanceolate acute, about 6mm long. Stamens are 10, longer than petals, have 5 ovaries, and the pollen is red, but gradually turns black [Changbok Lee, 1979, Daehanmunsa Seoul, p.402]. Wasong is harvested from summer to autumn, and the whole plant with its roots removed is dried in the sun for medicinal use [金在佶, 1984, 原色天然藥物大事典(上卷), Namsan堂, Seoul, p.447] .

와송을 본초학적으로 문헌을 통하여 고찰하여 보면 당본초(唐本草)에는 구중(口中)의 건조(乾燥)와 통증에 사용한다고 하며 본초강목에는 대장하혈에 물로 추출하여 복용하고, 모든 상처에 도포하면 수렴 효과가 있다고 하며 본초재신에는 백독(百毒)을 치료하고 종(腫)을 소실시키며 분류초약성에는 치질의 종통출혈을 다스리는 데는 약초를 전액(煎液)으로하여 세척한다고 하며 본초재신에는 창(瘡)과 유(癒)에 효과가 있다고 한다[上海科學技術出版社 小學館編 ;中藥大事典, 小學館, 1985, p.526].According to the herbalist review of Wasong in the literature, it is said that Dangboncho (唐本草) is used for dry mouth and pain (乾燥), extracting water from the subarachnoid blood of the large intestine and taking it, and applying it to all wounds. It is said to have an astringent effect, and herbal remedies are said to treat white poison (百毒) and eliminate bells (腫). It is said to be effective against (瘡) and oil (癒) [上海科学技術出版社 小学館編; 中藥大事典, 小学館, 1985, p.526].

이와 같은 와송은 피부 주름 개선효과(특허문헌 1), 바이오필름을 억제하는 효과(특허문헌 2)가 있음이 알려져 있다. It is known that such a wasong has an effect of improving skin wrinkles (Patent Document 1) and suppressing a biofilm (Patent Document 2).

본 출원의 발명자들은 위와 같은 와송 추출물이 혈당을 낮춤으로써 당뇨를 개선하는데 효능이 있는 것을 발견하고, 본 발명을 완성하였다. The inventors of the present application found that the Wasong extract as above is effective in improving diabetes by lowering blood sugar, and completed the present invention.

KR 10-1685581 B1 (2016. 12. 06.)KR 10-1685581 B1 (2016. 12. 06.) KR 10-2019-0082704 A (2019. 07. 10.)KR 10-2019-0082704 A (2019. 07. 10.)

본 발명에서 해결하고자 하는 과제는 식물 기반 추출물을 이용하여 당뇨를 개선, 예방 및 치료할 수 있는 조성물을 제공하는 것이다.An object to be solved in the present invention is to provide a composition capable of improving, preventing and treating diabetes using a plant-based extract.

위와 같은 과제를 해결하기 위한 본 발명에 따른 조성물은 와송 추출물을 유효성분으로 함유하여 당뇨를 예방하거나 개선하는 용도의 식품 조성물을 제공하는 것을 기술적 특징으로 한다. The composition according to the present invention for solving the above problems is characterized in that it contains a Wasong extract as an active ingredient to provide a food composition for preventing or improving diabetes.

위와 같은 과제를 해결하기 위한 본 발명에 따른 조성물은 와송 추출물을 유효성분으로 함유하여 당뇨를 예방하거나 치료하는 용도의 약학 조성물을 제공하는 것을 기술적 특징으로 한다. The composition according to the present invention for solving the above problems is characterized in that it contains a Wasong extract as an active ingredient to provide a pharmaceutical composition for preventing or treating diabetes.

본 발명에 따른 조성물은 식물을 이용하여 인체 내 부작용을 최소화시킬 수 있고, 혈당 수치를 정상범위로 낮춤과 동시에 췌장베타세포를 활성시킴으로써 효율적으로 당뇨병을 예방, 개선 또는 치료할 수 있다.The composition according to the present invention can minimize side effects in the human body using plants, and can effectively prevent, improve or treat diabetes by lowering blood sugar levels to a normal range and activating pancreatic beta cells at the same time.

도 1은 피하 및 복강 내 지방조직 부검 결과 사진(와송 주정추출물 기준)
도 2는 간의 지방조직 부검 결과 사진(와송 주정추출물 기준)
도 3은 피하 및 복강 내 지방조직 부검 결과 사진(와송 열수추출물 기준)
도 4는 간의 지방조직 부검 결과 사진(와송 열수추출물 기준)
도 5는 주수별 체중 측정 결과를 나타내는 그래프(와송 주정추출물 기준)
도 6은 부검 후 체중 측정 결과를 나타내는 그래프(와송 주정추출물 기준)
도 7은 부검 후 간 무게, 간 무게/체중 비율 및 신장 무게 결과를 나타내는 그래프(와송 주정추출물 기준)
도 8은 주수별 체중 측정 결과를 나타내는 그래프(와송 열수추출물 기준)
도 9는 부검 후 체중 측정 결과를 나타내는 그래프(와송 열수추출물 기준)
도 10은 부검 후 간 무게, 간 무게/체중 비율 및 신장 무게 결과를 나타내는 그래프(와송 열수추출물 기준)
도 11은 혈당 및 당화혈색소의 측정 결과를 나타내는 그래프(와송 주정추출물 기준)
도 12는 혈당 및 당화혈색소의 측정 결과를 나타내는 그래프(와송 열수추출물 기준)
도 13은 경구 당 부하검사 결과를 나타내는 그래프(와송 주정추출물 기준)
도 14는 경구 당 부하검사 결과를 나타내는 그래프(와송 열수추출물 기준)
도 15는 간 손상 수치(ALT, AST, BUN) 측정 결과를 나타내는 그래프(와송 주정추출물 기준)
도 16은 간 손상 수치(ALT, AST, BUN) 측정 결과를 나타내는 그래프(와송 열수추출물 기준)
도 17은 중성지방 및 총 콜레스테롤 측정 결과를 나타내는 그래프(와송 주정추출물 기준)
도 18은 중성지방 및 총 콜레스테롤 측정 결과를 나타내는 그래프(와송 열수추출물 기준)
도 19는 간의 H&E 염색 결과를 나타내는 사진(와송 주정추출물 기준)
도 20은 간의 H&E 염색 결과를 나타내는 사진(와송 열수추출물 기준)
도 21은 췌장의 H&E 염색 결과를 나타내는 사진(와송 주정추출물 기준)
도 22는 신장의 H&E 염색 결과를 나타내는 사진(와송 주정추출물 기준)
도 23은 신장의 H&E 염색 결과를 나타내는 사진(와송 열수추출물 기준)
도 24는 지질대사 및 지질생합성 관련 유전자의 발현 결과를 나타내는 그래프(와송 주정추출물 기준)
도 25는 지질대사 및 지질생합성 관련 유전자의 발현 결과를 나타내는 그래프(와송 열수추출물 기준)
도 26은 염증 관련 유전자의 발현 결과를 나타내는 그래프(와송 주정추출물 기준)
도 27은 당 수용체 및 당 신생합성 관련 유전자의 발현 결과를 나타내는 그래프(와송 주정추출물 기준)
도 28은 당 수용체 및 당 신생합성 관련 유전자의 발현 결과를 나타내는 그래프(와송 열수추출물 기준)
도 29는 인슐린 저항성 실험모델의 유전자 발현 분석 결과를 나타낸 그래프(와송 주정추출물 기준)
1 is a subcutaneous and intra-abdominal adipose tissue autopsy result photograph (based on wasong alcohol extract)
Figure 2 is a picture of the autopsy result of adipose tissue of the liver (based on wasong alcohol extract)
3 is a subcutaneous and intra-abdominal adipose tissue autopsy result photograph (based on wasong hot water extract)
4 is a picture of the autopsy result of adipose tissue of the liver (based on wasong hot water extract)
Figure 5 is a graph showing the weight measurement results by number of weeks (based on wasong alcohol extract)
6 is a graph showing the weight measurement results after autopsy (based on wasong alcohol extract)
7 is a graph showing the liver weight, liver weight / weight ratio, and kidney weight results after autopsy (based on wasong alcohol extract)
8 is a graph showing the weight measurement results for each week (based on wasong hot water extract)
9 is a graph showing the weight measurement results after autopsy (based on wasong hot water extract)
10 is a graph showing the liver weight, liver weight / weight ratio, and kidney weight results after autopsy (based on wasong hot water extract)
11 is a graph showing the measurement results of blood sugar and glycated hemoglobin (based on wasong alcohol extract)
12 is a graph showing the measurement results of blood sugar and glycated hemoglobin (based on wasong hot water extract)
13 is a graph showing the results of an oral glucose tolerance test (based on wasong alcohol extract)
14 is a graph showing the results of the oral glucose tolerance test (based on wasong hot water extract)
15 is a graph showing the measurement results of liver damage levels (ALT, AST, BUN) (based on wasong alcohol extract)
16 is a graph showing the measurement results of liver damage levels (ALT, AST, BUN) (based on wasong hot water extract)
17 is a graph showing the measurement results of triglycerides and total cholesterol (based on wasong alcohol extract)
18 is a graph showing the measurement results of triglycerides and total cholesterol (based on wasong hot water extract)
19 is a photograph showing the results of H & E staining of the liver (based on wasong alcohol extract)
20 is a photograph showing the results of H & E staining of the liver (based on wasong hot water extract)
Figure 21 is a photograph showing the results of H & E staining of the pancreas (based on wasong alcohol extract)
22 is a photograph showing the result of H & E staining of the kidney (based on wasong alcohol extract)
23 is a photograph showing the result of H & E staining of the kidney (based on wasong hot water extract)
24 is a graph showing the expression results of genes related to lipid metabolism and lipid biosynthesis (based on wasong alcohol extract)
25 is a graph showing the expression results of lipid metabolism and lipid biosynthesis related genes (based on wasong hot water extract)
26 is a graph showing the expression results of inflammation-related genes (based on wasong alcohol extract)
27 is a graph showing the expression results of glucose receptors and glucose neosynthesis-related genes (based on Wasong alcohol extract)
28 is a graph showing the expression results of glucose receptors and glucose neosynthesis-related genes (based on wasong hot water extract)
29 is a graph showing the results of gene expression analysis of the insulin resistance experimental model (based on wasong alcohol extract)

본 명세서 및 청구범위에 사용된 용어나 단어는 "발명자는 그 자신의 발명을 가장 최선의 방법으로 설명하기 위해 용어의 개념을 적절하게 정의할 수 있다는 원칙"에 입각하여 본 발명의 기술적 사상에 부합하는 의미와 개념으로 해석되어야지, 통상적이거나 사전적인 의미로 한정해서 해석되서는 안 된다.The terms or words used in the present specification and claims conform to the technical idea of the present invention based on the "principle that the inventor can appropriately define the concept of a term in order to best describe his invention" It should be interpreted as the meaning and concept that

따라서 본 명세서에 기재된 실시예와 도면에 도시된 구성은 본 발명의 가장 바람직한 실시예에 불과할 뿐이고, 본 발명의 기술적 사상을 모두 대변하는 것은 아니므로, 본 출원시점에 있어서 이들을 대체할 수 있는 다양한 균등물과 변형 예들이 있을 수 있음을 이해해야 한다.Therefore, the embodiments described in this specification and the configurations shown in the drawings are only the most preferred embodiments of the present invention, and do not represent all the technical ideas of the present invention, so various equivalents that can replace them at the time of the present application It should be understood that there may be water and variations.

실시예 1. 와송 열수추출물 제조Example 1. Wasong hot water extract preparation

와송은 남원에 소재한 영농조합법인으로부터 구매하였다. 와송 건조분말 1kg을 증류수 10L에 넣고 3시간 동안 100℃의 온도로 끓여 추출하였다. 추출물은 동결건조시켜 와송 열수추출물을 완성하였다.Wasong was purchased from the Agricultural Cooperative Corporation located in Namwon. 1 kg of wasong dry powder was put in 10 L of distilled water and extracted by boiling at a temperature of 100° C. for 3 hours. The extract was freeze-dried to complete the Wasong hot water extract.

실시예 2. 와송 주정추출물 제조Example 2. Wasong alcohol extract preparation

와송은 남원에 소재한 영농조합법인으로부터 구매하였다. 와송 건조분말 1kg을 주정 10L에 넣고 균질기(homogenizer)를 이용해 밤새 저으면서 2회에 걸쳐 환류추출하였다. 추출물은 동결건조시켜 와송 주정추출물을 완성하였다.Wasong was purchased from the Agricultural Cooperative Corporation located in Namwon. 1 kg of wasong dry powder was put into 10 L of alcohol, and the mixture was extracted under reflux twice while stirring overnight using a homogenizer. The extract was freeze-dried to complete the Wasong alcohol extract.

실험예 1. 부검 육안소견 및 간 무게, 체중 비교Experimental Example 1. Comparison of necropsy gross findings and liver weight and body weight

1-1. 실험 준비1-1. Experiment preparation

유전적 소인에 의해 제2형 당뇨병이 발현되는 모델인 db/db 마우스와 대조군인 db/+ 5주령 마우스를 각각 24마리, 32마리 입수하여 2주의 순화과정을 거쳐 7주령에 db/+ 마우스는 그룹 당 6마리, db/db 마우스는 그룹 당 8마리 씩 분류하였다. We obtained 24 and 32 db/db mice, a model for expressing type 2 diabetes by genetic predisposition, and db /+ 5-week-old mice, respectively, and after 2 weeks of acclimatization, db /+ mice at 7 weeks of age were obtained. 6 mice per group and 8 mice per group for db/db mice.

와송 주정추출물 및 열수추출물을 생리식염수에 녹여 주정추출물은 50, 100, 그리고 200 mg/mL, 열수추출물은 100, 200, 그리고 400 mg/ml 농도로 주 5회씩 8-10주 동안 경구 투여를 진행하였다.Dissolve wasong alcohol extract and hot water extract in physiological saline, and administer 50, 100, and 200 mg/mL for alcohol extract and 100, 200, and 400 mg/ml for hot water extract 5 times a week for 8-10 weeks. did.

1-2. 실험 과정1-2. experimental process

실험 기간 10주 후 부검을 실시하였다.After 10 weeks of the experiment, an autopsy was performed.

1-3. 실험 결과1-3. Experiment result

(1) 부검 육안소견 결과(1) Result of autopsy visual findings

당뇨가 유발된 db/db 마우스 그룹에서 db/+ 그룹에 비하여 피하 및 복강 내 지방조직의 크기가 증가된 것을 확인하였다. Compared to the db/+ group in the diabetic db/db mouse group, It was confirmed that the size of adipose tissue in the subcutaneous and abdominal cavity was increased.

반면, 도 1 및 도 2에 도시된 바와 같이 와송 주정추출물 투여에 의한 지방조직이나 간 모양 및 크기의 변화를 확인할 수 없었다. On the other hand, as shown in FIGS. 1 and 2, changes in the shape and size of adipose tissue or liver by the administration of Wasong alcohol extract could not be confirmed.

그리고 도 3 및 도 4에 도시된 바와 같이 와송 열수추출물 투여에 의한 지방조직이 미약하게 감소함을 확인하였으나 간 모양 및 크기의 변화는 확인할 수 없었다.And as shown in FIGS. 3 and 4, it was confirmed that the adipose tissue was slightly decreased by the administration of the Wasong hot water extract, but the change in the shape and size of the liver could not be confirmed.

(2)간 무게 및 체중 측정 결과(2) Liver weight and weight measurement results

당뇨가 유발된 db/db 마우스 그룹에서 db/+ 그룹에 비하여 체중 및 간의 무게가 증가한 결과를 확인하였다. Compared to the db/+ group in the diabetic db/db mouse group, The results of increased body weight and liver weight were confirmed.

반면 도 5 내지 도 7에 도시된 바와 같이 와송 주정추출물 투여에 의하여 체중은 유의성 있게 감소하는 것을 확인하였으나, 간 및 신장 무게의 통계적 유의성은 확인할 수 없었다. 이러한 결과로 와송 주정추출물 투여에 의하여 당뇨 유발 마우스에서 체중감소를 유도함을 확인하였다.On the other hand, as shown in FIGS. 5 to 7 , it was confirmed that the body weight was significantly reduced by administration of the Wasong alcohol extract, but the statistical significance of the liver and kidney weights could not be confirmed. As a result, it was confirmed that the administration of wasong alcohol extract induces weight loss in diabetic mice.

그리고 도 8 및 도 9에 도시된 바와 같이 와송 열수추출물 투여에 의하여 체중은 감소하는 양상은 확인하였으나, 통계적 유의성은 확인할 수 없었다. 도 10에 도시된 바와 같이 간 및 신장 무게 또한 와송 열수추출물의 투여에 의한 변화는 확인할 수 없었다. And as shown in FIGS. 8 and 9 , it was confirmed that the body weight decreased by administration of the Wasong hot water extract, but statistical significance could not be confirmed. As shown in FIG. 10, no change in liver and kidney weights due to administration of wasong hot water extract could be confirmed.

실험예 2. 항당뇨 지표에 대한 영향 평가Experimental Example 2. Evaluation of the effect on the antidiabetic index

2-1. 실험 준비2-1. Experiment preparation

1-1과 같이 마우스를 준비하였다.Mice were prepared as in 1-1.

2-2. 실험 과정2-2. experimental process

1-1의 마우스를 최소 8시간동안 절식한 후 (1)혈중 포도당 수치와 (2)당화혈색소 수치(HbA1c)를 측정하였고, 그 뒤 (3)당(2g/kg 체중)을 경구 투여하고 혈중 포도당 수치를 0, 30, 60, 90, 120분 후 각각 측정하여 혈당 조절 능력을 평가하였다. After fasting for at least 8 hours, (1) blood glucose level and (2) glycated hemoglobin level (HbA1c) were measured for 1-1 mice, and then (3) sugar (2 g/kg body weight) was orally administered and blood glucose level was measured. Glucose levels were measured after 0, 30, 60, 90, and 120 minutes, respectively, to evaluate the ability to control blood sugar.

2-3. 실험 결과2-3. Experiment result

(1)절식 후 혈당측정결과(1) Results of blood glucose measurement after fasting

도 11에 도시된 바와 같이 와송 주정추출물을 투여 받은 당뇨 유발 마우스 그룹에서 혈당이 유의적으로 감소하는 결과를 확인하였다. 이 결과를 바탕으로 초기 혈당수치와 차이를 비교분석 한 결과 혈당의 변화량 역시 와송 주정추출물 투여에 의하여 감소한 결과를 확인하였다.As shown in FIG. 11 , it was confirmed that blood sugar significantly decreased in the diabetic mouse group receiving the Wasong alcohol extract. Based on this result, as a result of comparative analysis of the difference with the initial blood sugar level, it was confirmed that the amount of change in blood sugar was also reduced by the administration of wasong alcohol extract.

그리고 도 12에 도시된 바와 같이 와송 열수추출물을 투여 받은 당뇨 유발 마우스 그룹에서 혈당이 미약하게 감소하는 결과를 확인하였다. 이 결과를 바탕으로 초기 혈당수치와 차이를 비교분석 한 결과 혈당의 변화량 역시 와송 열수추출물 투여에 의하여 미약하게 감소한 결과를 확인하였다.And as shown in FIG. 12 , it was confirmed that the blood glucose level was slightly decreased in the diabetic mouse group receiving the Wasong hot water extract. As a result of comparative analysis of the difference with the initial blood sugar level based on these results, it was confirmed that the amount of change in blood sugar was also slightly decreased by the administration of wasong hot water extract.

(2)당화혈색소(HbA1c) 측정결과(2) Glycated hemoglobin (HbA1c) measurement result

도 11에 도시된 바와 같이 와송 주정추출물을 투여 받은 당뇨 유발 마우스 그룹에서 당화혈색소의 측정값이 유의적으로 감소하는 것을 확인하였다.As shown in FIG. 11 , it was confirmed that the measured value of glycated hemoglobin significantly decreased in the diabetic-induced mouse group receiving the Wasong alcohol extract.

그리고 도 12에 도시된 바와 같이 와송 열수추출물의 고농도를 투여 받은 당뇨 유발 마우스 그룹에서 당화혈색소의 측정값이 유의적으로 감소하는 것을 확인하였다.And, as shown in FIG. 12 , it was confirmed that the measured value of glycated hemoglobin significantly decreased in the diabetic-induced mouse group that received the high concentration of Wasong hot water extract.

(3)경구 당 부하검사결과(oral glucose tolerance test)(3) Oral glucose tolerance test

db/db 마우스 그룹에서 혈당은 120분 후에도 초기 혈당에 비하여 현저히 증가 된 것을 확인하였다. In the db/db mouse group, it was confirmed that blood sugar was significantly increased compared to the initial blood sugar even after 120 minutes.

도 13에 도시된 바와 같이 와송 주정추출물 투여군의 경우, 당 투여 후 시간이 지남에 따라 혈당이 감소하는 유의적으로 감소하는 결과를 확인하였다. 이러한 결과로 와송 주정추출물 투여에 의하여 당뇨 유발 마우스에서 혈당 조절 능력이 개선됨을 나타낸다.As shown in FIG. 13 , in the case of the Wasong alcohol extract administered group, it was confirmed that the blood sugar decreased significantly over time after the administration of the sugar. These results indicate that the blood sugar control ability is improved in diabetic mice by administration of the Wasong alcohol extract.

그리고 도 14에 도시된 바와 같이 와송 열수추출물 투여군의 경우, 투여받지 않은 그룹에 비해 혈당이 유의적으로 감소하는 결과를 확인하였다. 이러한 결과로 와송 열수추출물 투여에 의하여 당뇨 유발 마우스에서 혈당 조절 능력이 개선됨을 나타낸다.And, as shown in FIG. 14 , in the case of the wasong hot water extract administered group, it was confirmed that the blood sugar significantly decreased compared to the non-administered group. These results indicate that the glycemic control ability is improved in diabetic mice by administration of the wasong hot water extract.

실험예 3. 당뇨병에 의한 간 손상 및 지방침착 확인Experimental Example 3. Diabetes-induced liver damage and fat deposition

3-1. 실험 준비3-1. Experiment preparation

1-1.과 같은 방법으로 마우스를 준비하였다.Mice were prepared in the same way as in 1-1.

3-2. 실험 과정3-2. experimental process

3-1의 마우스에서 채취한 혈액시료를 원심분리하여 혈청을 얻고, (1)간 손상 관련 효소인 ALT(alanine aminotransferase), AST(aspartate transaminase) 및 BUN(blood urea nitrogen)을 측정하였고, (2)3-1 마우스에서 채취한 간에서 중성지방(triglyceride, 이하 ‘TG’) 및 총 콜레스테롤의 양(total cholesterol, 이하 ‘TC’)을 측정하였다.Serum was obtained by centrifugation of blood samples collected from mice of 3-1, (1) liver damage-related enzymes ALT (alanine aminotransferase), AST (aspartate transaminase) and BUN (blood urea nitrogen) were measured, (2) ) 3-1 Triglyceride (hereinafter 'TG') and total cholesterol (total cholesterol, hereinafter 'TC') were measured in livers collected from mice.

3-3. 실험 결과3-3. Experiment result

(1)간 손상 수치 측정 결과(1) Results of liver damage measurement

도 15에 도시된 바와 같이 혈청학적 분석을 통하여 와송 주정추출물 투여에 의하여 ALT 및 AST 수치가 유의적으로 감소한 결과를 확인하였다. 이는 당뇨 유발 마우스의 간 손상이 와송 주정추출물 투여에 의하여 감소하는 것을 의미한다.As shown in FIG. 15 , it was confirmed through serological analysis that the ALT and AST levels were significantly decreased by the administration of the Wasong alcohol extract. This means that liver damage in diabetic mice is reduced by the administration of wasong alcohol extract.

혈청학적 분석을 통하여 와송 주정추출물 투여에 의하여 BUN 수치는 차이가 없음을 확인하였다.Through serological analysis, it was confirmed that there was no difference in the BUN level by the administration of Wasong alcohol extract.

그리고 도 16에 도시된 바와 같이 혈청학적 분석을 통하여 와송 열수추출물 투여에 의하여 AST 수치가 유의적으로 감소한 결과를 확인하였다. 그러나 ALT 수치에서는 통계적으로 유의성 있는 결과를 확인할 수 없었다. 이는 당뇨 유발 마우스의 간 손상이 와송 열수추출물 투여에 의하여 감소하는 것을 의미한다.And, as shown in FIG. 16, it was confirmed through serological analysis that the AST level was significantly decreased by the administration of the Wasong hot water extract. However, no statistically significant results were found in the ALT level. This means that liver damage in diabetic mice was reduced by administration of wasong hot water extract.

혈청학적 분석을 통하여 당뇨가 유발된 db/db 마우스 그룹에서 db/+ 그룹에 비하여 증가한 BUN 수치가 와송 열수추출물 투여에 의하여 감소하는 결과를 확인하였다.Through serological analysis, it was confirmed that the BUN level increased in the diabetic db/db mouse group compared to the db/+ group was decreased by the administration of the Wasong hot water extract.

(2)TG 및 TC 측정 결과(2) TG and TC measurement results

도 17에 도시된 바와 같이 간에서 중성지방 및 콜레스테롤의 양을 측정한 결과 와송 주정추출물 투여에 의하여 지방 축적이 유의적으로 감소한 결과를 확인하였다As shown in FIG. 17, as a result of measuring the amount of triglyceride and cholesterol in the liver, it was confirmed that the fat accumulation was significantly reduced by the wasong alcohol extract administration.

그리고 도 18에 도시된 바와 같이 간에서 중성지방 및 콜레스테롤의 양을 측정한 결과 와송 열수추출물 투여에 의하여 지방 축적의 차이를 확인할 수 없었다.And as shown in FIG. 18, as a result of measuring the amounts of triglycerides and cholesterol in the liver, the difference in fat accumulation could not be confirmed by the administration of the Wasong hot water extract.

실험예 4. 간의 조직병리학적 변화 분석Experimental Example 4. Analysis of histopathological changes in the liver

4-1. 실험 준비4-1. Experiment preparation

실험예 1에서 부검된 마우스의 간 조직을 준비하였다.The liver tissue of the mouse autopsied in Experimental Example 1 was prepared.

4-2. 실험 과정4-2. experimental process

포르말린 고정 후 일반적인 처리과정을 거친 조직절편을 H&E 염색을 통하여 당뇨유발에 의한 간의 병리학적 변화를 관찰하였다.After formalin fixation, hepatic pathological changes caused by diabetes were observed through H&E staining of tissue sections that had undergone a general treatment process.

4-3. 실험 결과4-3. Experiment result

와송 주정추출물 투여군의 경우, 도 19에 도시된 바와 같이 간의 H&E 염색 결과 db/db 마우스 군에서 간세포 변성(hepatocellular hypertrophy, ballooning degeneration) 및 지방침착(stratosis)을 관찰할 수 있었으며, 이러한 양상은 와송 주정추출물 투여에 의해 유의적으로 감소되는 것을 확인하였다.In the case of the Wasong alcohol extract administration group, as shown in FIG. 19 , hepatocellular hypertrophy (ballooning degeneration) and stratosis were observed in the db/db mouse group as a result of liver H&E staining, and this aspect is the Wasong alcohol It was confirmed that it was significantly reduced by administration of the extract.

그리고 와송 열수추출물 투여군의 경우, 도 20에 도시된 바와 같이 간의 H&E 염색 결과 db/db 마우스 군에서 간세포 변성 및 지방침착을 관찰할 수 있었으며, 이러한 양상은 와송 열수추출물 투여에 의해 미약하게 감소되는 것을 확인하였다.And in the case of the Wasong hot water extract administration group, as shown in FIG. 20 , hepatocyte degeneration and fat deposition were observed in the db/db mouse group as a result of H&E staining of the liver, and this aspect was slightly reduced by the administration of the Wasong hot water extract. Confirmed.

실험예 5. 췌장의 조직병리학적 변화 분석Experimental Example 5. Analysis of histopathological changes in the pancreas

5-1. 실험 준비5-1. Experiment preparation

실험예 1에서 부검된 마우스의 췌장 조직을 준비하였다.The pancreas tissue of the mouse autopsied in Experimental Example 1 was prepared.

5-2. 실험 과정5-2. experimental process

포르말린 고정 후 일반적인 처리과정을 거친 조직절편을 H&E 염색을 통하여 당뇨유발에 의한 췌장의 병리학적 변화를 관찰하였다.Pathological changes in the pancreas due to diabetes were observed through H&E staining of tissue sections that had undergone a general treatment after formalin fixation.

5-3. 실험 결과5-3. Experiment result

와송 주정추출물 투여군의 경우, 도 21에 도시된 바와 같이 췌장 H&E 염색 결과 인슐린 저항성으로 인한 췌장의 랑게르한스 섬 면적이 현저히 증가한 것이 db/db 마우스 군에서 관찰되었다. 이러한 변화는 와송 주정추출물 투여에 의하여 감소하는 것을 확인하였다. In the case of the Wasong alcohol extract administered group, as shown in FIG. 21 , as a result of pancreatic H&E staining, a marked increase in the area of the islet of Langerhans in the pancreas due to insulin resistance was observed in the db/db mouse group. It was confirmed that these changes were reduced by the administration of wasong alcohol extract.

실험예 6. 신장의 조직병리학적 변화 분석Experimental Example 6. Analysis of histopathological changes in the kidney

6-1. 실험 준비6-1. Experiment preparation

실험예 1에서 부검된 마우스의 신장 조직을 준비하였다.The kidney tissue of the mouse autopsied in Experimental Example 1 was prepared.

6-2. 실험 과정6-2. experimental process

포르말린 고정 후 일반적인 처리과정을 거친 조직절편을 H&E 염색을 통하여 당뇨유발에 의한 신장의 병리학적 변화를 관찰하였다.After formalin fixation, the tissue sections that had undergone the general treatment process were subjected to H&E staining to observe pathological changes in the kidneys due to diabetes induction.

6-3. 실험 결과6-3. Experiment result

와송 주정추출물 투여군의 경우, 도 22에 도시된 바와 같이 염색을 통하여 당뇨 유발 마우스에서 와송 주정추출물 투여에 의한 신장의 조직병리 변화를 관찰한 결과, 신장 사구체의 손상 및 글리코겐 침착에 큰 차이가 없는 결과를 확인하였다.In the case of the Wasong alcohol extract-administered group, as shown in FIG. 22, as a result of observing changes in kidney histopathology by administration of the Wasong alcohol extract in diabetic mice through staining, there was no significant difference in renal glomerular damage and glycogen deposition. was confirmed.

그리고 와송 열수추출물 투여군의 경우, 도 23에 도시된 바와 같이 염색을 통하여 당뇨 유발 마우스에서 와송 열수추출물 투여에 의한 신장의 조직병리 변화를 관찰한 결과, 신장 사구체의 손상 및 글리코겐 침착에 큰 차이가 없는 결과를 확인하였다.And in the case of the wasong hot water extract administration group, as shown in FIG. 23, as a result of observing the change of kidney histopathology by administration of the wasong hot water extract in diabetic mice through staining, there was no significant difference in renal glomerular damage and glycogen deposition. The results were confirmed.

실험예 7. 지방 관련 유전자 발현 분석Experimental Example 7. Fat-related gene expression analysis

7-1. 실험 과정7-1. experimental process

실험예 1에서 부검된 마우스의 간 조직에서 mRNA를 추출하여 cDNA를 합성하였다. 다양한 유전자의 발현 변화를 qRT-PCR을 통해 상대정량분석을 실시하여 와송·여주 복합추출물 의한 유전자 발현양상의 변화를 비교분석하였다.cDNA was synthesized by extracting mRNA from the liver tissue of the mouse autopsied in Experimental Example 1. Relative quantitative analysis was performed on the expression changes of various genes through qRT-PCR to compare and analyze the changes in gene expression patterns caused by the Wasong-Yeoju complex extract.

7-2. 실험 결과7-2. Experiment result

와송 주정추출물 투여군의 경우, 도 24에 도시된 바와 같이 지질대사 관련 인자인 Apo B, LPL, L-FABP, 및 FABP4의 발현을 비교분석한 결과 와송 주정추출물 투여에 의하여 당뇨 유발 마우스의 간장에서 유의적으로 감소하는 결과를 확인하였다.In the case of the Wasong alcohol extract administered group, as shown in FIG. 24, the expression of Apo B, LPL, L-FABP, and FABP4, which are lipid metabolism-related factors, was comparatively analyzed. As a result, it was significant in the liver of diabetic mice by the Wasong alcohol extract administration. A negative decrease was confirmed.

지질생합성(de novo lipogenesis)관련 인자인 ACCα, ACCβ, FASN, 및 SCD1의 발현을 비교분석한 결과 와송 주정추출물 투여에 의하여 당뇨 유발 마우스의 간장에서 유의적으로 감소하는 결과를 확인하였다.As a result of comparative analysis of the expression of ACCα, ACCβ, FASN, and SCD1, which are factors related to lipid biosynthesis ( de novo lipogenesis), it was confirmed that the administration of Wasong alcohol extract significantly decreased the liver of diabetic mice.

이러한 변화와 밀접한 연관이 있는 전자조절인자 및 그 관련 인자인 SREBP-1, SREBP-2, LXRα, 및 LXRβ의 발현을 비교분석한 결과 와송 주정추출물 투여에 의하여 당뇨 유발 마우스의 간장에서 유의적으로 감소하는 결과를 확인하였다. 반면 간 보호 및 항 당뇨효능이 있다고 알려져 있는 PPARα의 발현은 미약하게 증가하는 양상을 확인하였다.As a result of comparative analysis of the expression of electronic regulators closely related to these changes and their related factors, SREBP-1, SREBP-2, LXRα, and LXRβ, it was significantly reduced in the liver of diabetic mice by administration of wasong alcohol extract. The result was confirmed. On the other hand, it was confirmed that the expression of PPARα, which is known to have hepatoprotective and antidiabetic effects, slightly increased.

그리고 와송 열수추출물 투여군의 경우, 도 25에 도시된 바와 같이 지질대사 관련 인자인 L-FABP, ApoB의 발현을 비교분석한 결과 와송 열수추출물 투여에 의하여 ApoB에서 당뇨 유발 마우스의 간장에서 유의적으로 감소하는 결과를 확인하였다.And in the case of the wasong hot water extract administration group, as shown in FIG. 25, as a result of comparative analysis of the expression of L-FABP and ApoB, which are factors related to lipid metabolism, ApoB significantly decreased in the liver of diabetic mice by administration of the wasong hot water extract. The result was confirmed.

지질생합성(de novo lipogenesis)관련 인자인 ACCα, ACCβ, 및 FASN의 발현을 비교분석한 결과 ACCα, ACCβ의 발현이 와송 열수추출물 투여에 의하여 당뇨 유발 마우스의 간장에서 유의적으로 감소하는 결과를 확인하였다.As a result of comparative analysis of the expression of ACCα, ACCβ, and FASN, which are factors related to de novo lipogenesis, it was confirmed that the expression of ACCα and ACCβ was significantly reduced in the liver of diabetic mice by administration of wasong hot water extract. .

이러한 변화와 밀접한 연관이 있는 전자조절인자 및 그 관련 인자인 LXRα, LXRβ의 발현을 비교분석한 결과 와송 열수추출물 투여에 의하여 당뇨 유발 마우스의 간장에서 통계적인 유의성은 확인할수 없었으나 미약하게 감소하는 결과를 확인하였다. 반면 간 보호 및 항 당뇨효능이 있다고 알려져 있는 PPARα의 발현은 미약하게 증가하는 양상을 확인하였다.As a result of comparative analysis of the expression of electronic regulators closely related to these changes and their related factors, LXRα and LXRβ, statistical significance could not be confirmed in the liver of diabetic mice by the administration of hot water extract of Wasong, but it was slightly decreased. was confirmed. On the other hand, it was confirmed that the expression of PPARα, which is known to have hepatoprotective and antidiabetic effects, slightly increased.

실험예 8. 염증 관련 유전자 발현 분석Experimental Example 8. Inflammation-related gene expression analysis

8-1. 실험 과정8-1. experimental process

실험예 1에서 부검된 마우스의 간 조직에서 mRNA를 추출하여 cDNA를 합성하였다. 다양한 유전자의 발현 변화를 qRT-PCR을 통해 상대정량분석을 실시하여 와송·여주 복합추출물 의한 유전자 발현양상의 변화를 비교분석하였다.cDNA was synthesized by extracting mRNA from the liver tissue of the mouse autopsied in Experimental Example 1. Relative quantitative analysis was performed on the expression changes of various genes through qRT-PCR to compare and analyze changes in gene expression patterns caused by the Wasong-Yeoju complex extract.

8-2. 실험 결과8-2. Experiment result

염증관련 대표인자인 TNF-α, IL-6, 및 IL-1β의 발현을 확인해 본 결과, 도 26에 도시된 바와 같이 와송 주정추출물을 투여한 마우스의 간에서 유의적으로 감소하는 결과를 확인하였다. As a result of confirming the expression of TNF-α, IL-6, and IL-1β, which are representative inflammation-related factors, it was confirmed that the result was significantly decreased in the liver of the mice administered the Wasong alcohol extract as shown in FIG. .

이러한 분석 결과를 바탕으로, 와송 주정추출물의 처리가 염증인자의 발현을 억제시킴으로써 간 손상을 감소시킴을 확인하였다.Based on these analysis results, it was confirmed that the treatment of Wasong alcohol extract reduces liver damage by suppressing the expression of inflammatory factors.

실험예 9. 당 대사 관련 유전자 발현 분석Experimental Example 9. Analysis of gene expression related to sugar metabolism

9-1. 실험 과정9-1. experimental process

실험예 1에서 부검된 마우스의 간 조직에서 mRNA를 추출하여 cDNA를 합성하였다. 다양한 유전자의 발현 변화를 qRT-PCR을 통하여 상대정량분석을 실시하여 와송 주정추출물에 의한 유전자 발현양상의 변화를 비교분석하였다.cDNA was synthesized by extracting mRNA from the liver tissue of the mouse autopsied in Experimental Example 1. Relative quantitative analysis was performed on the expression changes of various genes through qRT-PCR to compare and analyze the changes in gene expression patterns caused by the Wasong alcohol extract.

9-2. 실험 결과9-2. Experiment result

와송 주정추출물의 경우, 도 27에 도시된 바와 같이 당 수용체(GLUT2, GLUT4)의 발현을 확인해 본 결과, 당 수용체 발현이 와송 주정추출물 투여에 의하여 유의적인 차이가 없음을 확인하였다.In the case of the Wasong alcohol extract, as shown in FIG. 27 , the expression of the sugar receptors (GLUT2, GLUT4) was confirmed. As a result, it was confirmed that there was no significant difference in the expression of the sugar receptors by the administration of the Wasong alcohol extract.

당 신생합성 관련 유전자(G6Pase, PEPCK)의 발현을 확인해 본 결과, 와송 주정추출물 처리에 의하여 당뇨 유발 마우스 간에서 당 신생합성 관련 유전자인 G6Pase의 발현이 유의적으로 감소하는 결과를 확인하였다.As a result of confirming the expression of gluconeogenesis-related genes (G6Pase, PEPCK), it was confirmed that the expression of G6Pase, a gluconeogenesis-related gene, was significantly decreased in the liver of diabetic mice by the wasong alcohol extract treatment.

이러한 분석 결과를 바탕으로, 와송 주정추출물의 처리가 인슐린 신호전달을 활성화시며, 간장의 당 신생 억제 및 당 유입을 증가시킴으로써 혈당 조절에 좋은 역할을 하는 것을 확인하였다.Based on these analysis results, it was confirmed that the treatment of Wasong alcohol extract activates insulin signaling and plays a good role in glycemic control by inhibiting hepatic gluconeogenesis and increasing glucose inflow.

그리고 와송 열수추출물의 경우, 도 28에 도시된 바와 같이 당 수용체(GLUT2, GLUT4)의 발현을 확인해 본 결과, 당 수용체 발현이 와송 열수추출물 투여에 의하여 유의하게 증가하는 결과를 확인하였다.And in the case of the wasong hot water extract, as shown in FIG. 28, as a result of confirming the expression of the sugar receptors (GLUT2, GLUT4), it was confirmed that the expression of the sugar receptor was significantly increased by administration of the wasong hot water extract.

당 신생합성 관련 유전자(G6Pase)의 발현을 확인해 본 결과, 와송 주정추출물 처리에 의하여 당뇨 유발 마우스 간에서 당 신생합성 관련 유전자인 G6Pase의 발현이 미약하게 감소하는 결과를 확인하였다.As a result of confirming the expression of the gluconeogenesis-related gene (G6Pase), it was confirmed that the expression of G6Pase, a gluconeogenesis-related gene, was slightly decreased in the liver of diabetic mice by the wasong alcohol extract treatment.

이러한 분석 결과를 바탕으로, 와송 주정추출물의 처리가 인슐린 신호전달을 활성화시며, 간장의 당 신생 억제 및 당 유입을 증가시킴으로써 혈당 조절에 좋은 역할을 하는 것을 확인하였다.Based on these analysis results, it was confirmed that the treatment of Wasong alcohol extract activates insulin signaling and plays a good role in glycemic control by inhibiting hepatic gluconeogenesis and increasing glucose inflow.

실험예 10. 항당뇨 효능 Experimental Example 10. Antidiabetic Efficacy in vitroin vitro 평가 evaluation

10-1. 실험 과정10-1. experimental process

간암세포주인 HepG2 cell에 PA를 0.4mM 농도로 처리하거나, High Glucose(4.5g/mL)+Insulin(2.5㎍/mL)을 처리하여 인슐린저항성, 지방 축적 및 세포손상을 유발하였다.HepG2 cells, a hepatocarcinoma cell line, were treated with either PA at a concentration of 0.4 mM or High Glucose (4.5 g/mL) + Insulin (2.5 μg/mL) to induce insulin resistance, fat accumulation and cell damage.

세포독성이 없는 와송 주정추출물의 농도를 확인 후 3가지 농도를 결정하여 처리 후 24시간 배양하였다. After confirming the concentration of wasong alcohol extract without cytotoxicity, three concentrations were determined and cultured for 24 hours after treatment.

다양한 유전자의 발현 변화를 qRT-PCR을 통하여 상대정량분석을 실시하여 와송 주정추출물에 의한 유전자 발현양상의 변화를 세포수준에서 비교분석하였다.Relative quantitative analysis was performed on the expression changes of various genes through qRT-PCR to compare and analyze changes in gene expression patterns caused by the Wasong alcohol extract at the cellular level.

통계적으로 세포독성이 일어나지 않는 3가지 농도(10ng/mL, 100ng/mL, 1μg/mL)를 설정함.Three concentrations (10 ng/mL, 100 ng/mL, and 1 μg/mL) at which cytotoxicity does not occur statistically were established.

10-2. 실험 결과10-2. Experiment result

도 29를 참고하면, 와송 주정추출물의 처리가 PA 또는 High glucose+Insulin이 처리된 간세포에서 GLUT4를 유의적으로 증가시키는 것을 확인하였고, G6Pase의 발현은 High glucose+insulin 모델에서 유의적으로 감소하는 결과를 확인하였다.Referring to FIG. 29 , it was confirmed that the treatment of Wasong alcohol extract significantly increased GLUT4 in hepatocytes treated with PA or high glucose+insulin, and the expression of G6Pase was significantly decreased in the high glucose+insulin model. was confirmed.

와송 주정추출물의 처리가 PA 또는 High glucose+Insulin이 처리된 간세포에서 PPARα의 발현이 증가하는 결과를 확인하였다.It was confirmed that the treatment of Wasong alcohol extract increased the expression of PPARα in hepatocytes treated with PA or high glucose+Insulin.

와송 주정추출물의 처리가 PA 또는 High glucose+Insulin이 처리된 간세포에서 염증인자의 발현을 감소시켜 생체 내 실험결과와 유사함을 확인하였다.It was confirmed that the treatment of Wasong alcohol extract reduced the expression of inflammatory factors in hepatocytes treated with PA or high glucose + Insulin, which was similar to the in vivo experimental results.

이러한 결과를 바탕으로 와송 주정추출물의 항 당뇨 효능이 세포수준에서도 효과적으로 작용함을 확인하였다.Based on these results, it was confirmed that the anti-diabetic effect of Wasong alcohol extract was effective at the cellular level.

Claims (4)

와송 추출물을 유효성분으로 함유하는 당뇨 예방 또는 개선용 식품 조성물.
A food composition for preventing or improving diabetes containing Wasong extract as an active ingredient.
청구항 1에 있어서,
상기 와송 추출물은 주정추출물인 것을 특징으로 하는 당뇨 예방 또는 개선용 식품 조성물.
The method according to claim 1,
The Wasong extract is a food composition for preventing or improving diabetes, characterized in that it is an alcohol extract.
청구항 1에 있어서,
상기 당뇨는 2형 당뇨인 것을 특징으로 하는 당뇨 예방 또는 개선용 식품 조성물.
The method according to claim 1,
The diabetes is a food composition for preventing or improving diabetes, characterized in that type 2 diabetes.
와송 추출물을 유효성분으로 함유하는 당뇨 예방 또는 치료용 약학 조성물.

A pharmaceutical composition for preventing or treating diabetes containing a Wasong extract as an active ingredient.

KR1020190167097A 2019-12-13 2019-12-13 Composition comprising extracts of Orostachys japonicus as an active ingredient for preventing, alleviating or treating diabetes KR20210075705A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1020190167097A KR20210075705A (en) 2019-12-13 2019-12-13 Composition comprising extracts of Orostachys japonicus as an active ingredient for preventing, alleviating or treating diabetes

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020190167097A KR20210075705A (en) 2019-12-13 2019-12-13 Composition comprising extracts of Orostachys japonicus as an active ingredient for preventing, alleviating or treating diabetes

Publications (1)

Publication Number Publication Date
KR20210075705A true KR20210075705A (en) 2021-06-23

Family

ID=76599239

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020190167097A KR20210075705A (en) 2019-12-13 2019-12-13 Composition comprising extracts of Orostachys japonicus as an active ingredient for preventing, alleviating or treating diabetes

Country Status (1)

Country Link
KR (1) KR20210075705A (en)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101685581B1 (en) 2015-08-12 2016-12-12 김수경 Compositions for improving skin wrinkle or moisture comprising Orostachys japonicus and composition prepared therefrom
KR20190082704A (en) 2019-07-01 2019-07-10 인제대학교 산학협력단 Composition for repressing or removing Staphylococcus spp. biofilm comprising the extract of Orostachys japonicas

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101685581B1 (en) 2015-08-12 2016-12-12 김수경 Compositions for improving skin wrinkle or moisture comprising Orostachys japonicus and composition prepared therefrom
KR20190082704A (en) 2019-07-01 2019-07-10 인제대학교 산학협력단 Composition for repressing or removing Staphylococcus spp. biofilm comprising the extract of Orostachys japonicas

Similar Documents

Publication Publication Date Title
CN101277710B (en) Antiobesity composition
Gohil et al. Treatment with extracts of Eugenia jambolana seed and Aegle marmelos leaf extracts prevents hyperglycemia and hyperlipidemia in alloxan induced diabetic rats
Luo et al. Sweet potato (Ipomoea batatas L.) leaf polyphenols ameliorate hyperglycemia in type 2 diabetes mellitus mice
Thomas et al. The significance of Tinospora crispa in treatment of diabetes mellitus
KR101090319B1 (en) A composition having an effect of curing and preventing diabetes mellitus
Wang et al. p-Synephrine ameliorates alloxan-induced diabetes mellitus through inhibiting oxidative stress and inflammation via suppressing the NF-kappa B and MAPK pathways
Onaolapo et al. Ocimum Gratissimum Linn causes dose dependent hepatotoxicity in streptozotocin-induced diabetic Wistar rats
CN101336974B (en) Traditional Chinese medicine for reducing blood sugar and regulating lipid with overall regulation of body metabolism and preparation method thereof
KR100831621B1 (en) The plant extracts composition for the blood glucose reducing action
US20030232099A1 (en) Health-care products and methods for preparing and using the same
CN101856418A (en) Pharmaceutical preparation for preventing nephritis and preparation method thereof
KR20210075705A (en) Composition comprising extracts of Orostachys japonicus as an active ingredient for preventing, alleviating or treating diabetes
CN105012826A (en) Alpinia oxyphylla leaf extract and preparation method and application thereof
CN101926852A (en) Application of roots and leaves of common fig in preparing auxiliary therapy medicine and health food for hepatitis
KR102488212B1 (en) Orostachys japonicas and Momordica charantia Linn complex-extract for improving blood sugar and method of manufacturing the same
KR101303541B1 (en) A composition having effects of preventing alcoholic liver damage and alcoholic fat liver and of ameliorating hangover
CN113068832A (en) A health product with effects of nourishing liver and kidney, fixing hair, and preventing alopecia, and its preparation method
KR20100111088A (en) Composition for preventing and treating diabetes mellitus or diabetic complications comprising extract of herbal combination
Pochhi An antioxidant activity of Cinnamonum tamala improves histopathological alterations and biochemical parameters in alloxan induced diabetic rats
CN101269152A (en) Application of matrimony vine and black fungus in preparing fatty liver resistant medicament
CN106215043A (en) A kind of roxburgh anoectochilus terminal bud buccal tablet with effect of lowering blood sugar and preparation method thereof
CN109966283A (en) Application of the degreasing cinnamon polyphenol extract in preparation prevention and treatment diabetic nephropathy product
Mirsky Glucose tolerance factor–insulin mimetic and potentiating agent–a source for a novel anti diabetic medication
Helal et al. Ameliorative effects of artemisia judaica l. extract against alloxan-induced biochemical alterations in male wistar rats
Nadro et al. Anti-diabetic effects of aqueous extract and oil of Moringa oleifera seed on liver and kidney functions in Streptozotocin-induced diabetes in Rats

Legal Events

Date Code Title Description
E902 Notification of reason for refusal
AMND Amendment
E601 Decision to refuse application
AMND Amendment
X601 Decision of rejection after re-examination
J201 Request for trial against refusal decision
J301 Trial decision

Free format text: TRIAL NUMBER: 2023101000057; TRIAL DECISION FOR APPEAL AGAINST DECISION TO DECLINE REFUSAL REQUESTED 20230109

Effective date: 20231114